MedPath

Comparing cognition functions of breast surgery patients receiving either ketamine or dexmedetomidine treatment during surgery

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/08/057031
Lead Sponsor
Jawaharlal Institute of Postgraduate Medical Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Adult patients aged 18 to 65 years undergoing modified radical mastectomy.

2.American society of Anesthesiologists (ASA) status 1-3

Exclusion Criteria

1.History of dementia or Montreal cognition assessment score less than 26

2.severe audio-visual impairments and illiterate patients.

3.Allergy to any of the drugs used in the study including ketamine and dexmedetomidine.

4.patients receiving regional blocks for postoperative analgesia for MRM

5. ischemic heart disease and uncontrolled hypertension, severe pulmonary disease, heart failure (New York Heart Association class > II).

6. History of known psychiatric/ neurodegenerative disorder

7. Hepatic or renal impairment.

8. patients taking sedatives, antidepressants and glucocorticoids

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath